BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 226 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q1 2021. The put-call ratio across all filers is 1.62 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $2,917,000 | +3.8% | 19,293 | 0.0% | 0.01% | 0.0% |
| Q2 2022 | $2,811,000 | +32.5% | 19,293 | +7.8% | 0.01% | +75.0% |
| Q1 2022 | $2,122,000 | -23.1% | 17,893 | -10.6% | 0.00% | -20.0% |
| Q4 2021 | $2,760,000 | -6.9% | 20,025 | -6.1% | 0.01% | -16.7% |
| Q3 2021 | $2,963,000 | +45.8% | 21,332 | +1.9% | 0.01% | +50.0% |
| Q2 2021 | $2,032,000 | +53.1% | 20,932 | +7.8% | 0.00% | +33.3% |
| Q1 2021 | $1,327,000 | -20.3% | 19,419 | +0.1% | 0.00% | 0.0% |
| Q4 2020 | $1,664,000 | +18.9% | 19,409 | -9.8% | 0.00% | 0.0% |
| Q3 2020 | $1,399,000 | +1.9% | 21,519 | +14.6% | 0.00% | 0.0% |
| Q2 2020 | $1,373,000 | +114.9% | 18,779 | 0.0% | 0.00% | +50.0% |
| Q1 2020 | $639,000 | -37.5% | 18,779 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $1,022,000 | +30.5% | 18,779 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $783,000 | -5.7% | 18,779 | -0.9% | 0.00% | 0.0% |
| Q2 2019 | $830,000 | +1.3% | 18,948 | +19.0% | 0.00% | 0.0% |
| Q1 2019 | $819,000 | +37.9% | 15,918 | -0.9% | 0.00% | 0.0% |
| Q4 2018 | $594,000 | -0.7% | 16,058 | +0.9% | 0.00% | 0.0% |
| Q3 2018 | $598,000 | -4.9% | 15,913 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $629,000 | +91.2% | 15,913 | +24.7% | 0.00% | +100.0% |
| Q1 2018 | $329,000 | – | 12,763 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 896,844 | $123,594,000 | 67.92% |
| RP Management, LLC | 1,111,111 | $153,122,000 | 64.09% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,075,402 | $286,011,000 | 40.64% |
| ARS Investment Partners, LLC | 463,392 | $63,860,000 | 5.86% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 300,373 | $41,394,000 | 4.76% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 80,348 | $11,073,000 | 4.49% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 139,900 | $19,282,000 | 4.30% |
| Avidity Partners Management LP | 1,140,000 | $157,103,000 | 3.33% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 200,000 | $27,562,000 | 3.17% |
| Eventide Asset Management | 1,635,000 | $225,319,000 | 2.88% |